Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-15

Clinical Trial Update: Can Tadalafil Maintain Erectile Function In Patients Treated With Radiotherapy For Prostate Cancer? [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating tadalafil to maintain erectile function in patients with prostate cancer treated with radiotherapy; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TADALAFIL (TADALAFIL)

Snippet

Sponsor: Erasmus Medical Center | Conditions: Prostate Cancer, Erectile Dysfunction | Phase 3 | Status: TERMINATED